NIH-funded research Fellowship grant

Understanding how FGF proteins influence cell movement

Official title: Investigating FGF Signaling Dynamics in migrating cells

Funded at University of Virginia · NIH-11030216 · Data updated 2026-11-12

This study looks at how a special protein called FGF helps cells move around in a tiny worm, which can teach us more about how cells behave during development and could help us understand issues like cancer spread.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$38,427
NIH project number5F31HD112152-02
Project IDNIH-11030216 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to abnormal cell migration, such as certain cancers.

Less likely to help

Patients with conditions unrelated to cell migration or those not affected by FGF signaling may not benefit from this research.

What this research studies

This research investigates the dynamics of Fibroblast Growth Factor (FGF) signaling in migrating cells, specifically using a model organism, C. elegans. By visualizing key signaling proteins and manipulating their activity, the study aims to uncover how FGF influences cell migration during development. The research employs advanced imaging techniques to observe the behavior of muscle progenitor cells as they migrate, providing insights into the mechanisms of cell movement and signaling. This could enhance our understanding of processes relevant to cancer metastasis and other conditions.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for controlling cell migration, which is crucial in cancer treatment and tissue regeneration.

How similar studies have gone: Previous research has shown success in understanding cell signaling dynamics, but this specific approach using FGF in C. elegans is relatively novel.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Gibney, Theresa — University of Virginia
  • Study coordinator: Gibney, Theresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.